Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1984;6:551-556

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldberg, M. R.
Right arrow Articles by Robertson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldberg, M. R.
Right arrow Articles by Robertson, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*EPINEPHRINE
*PHENYLEPHRINE
*PRAZOSIN HYDROCHLORIDE

Hypertension, Vol 6, 551-556, Copyright © 1984 by American Heart Association


ARTICLES

Evidence for the existence of vascular alpha 2-adrenergic receptors in humans

MR Goldberg and D Robertson

Many studies have suggested that alpha-adrenergic receptors on vascular smooth muscle are heterogeneous and that both alpha 1- and alpha 2- adrenergic receptors can cause vasoconstriction when stimulated. We explored this hypothesis in normal humans by comparing the capacity of yohimbine, an alpha 2-adrenergic receptor antagonist, and prazosin, an alpha 1-adrenergic receptor agonist, with differentially blocked pressor responses to phenylephrine, an alpha 1-adrenergic receptor agonist, and epinephrine, a nonselective alpha-agonist. We studied these responses in normal male volunteers who had been pretreated with propranolol (80 mg orally every 8 hours for 5 days) to obviate stimulation of beta-receptors by either agonist. We found differential effects of the antagonists on responses to the two agonists. Yohimbine induced a 3.1-fold (+/- 0.5) shift in the dose of epinephrine, which raised blood pressure 25 mm Hg, and only a 1.9-fold (+/- 0.2) shift in the response to phenylephrine (p less than 0.01). Prazosin induced a 2.4-fold (+/- 0.5) shift in the responses to epinephrine and a 4.5-fold (+/- 1.2) shift in the response to phenylephrine (p less than 0.05). These data are consistent with the notion that alpha-adrenergic receptors in the human vasculature are not homogeneous, but rather may be subdivided into at least two subtypes, one resembling alpha 1- adrenergic receptors and the other resembling alpha 2-adrenergic receptors.


This article has been cited by other articles:


Home page
HypertensionHome page
J. R. Shannon, J. Jordan, B. K. Black, F. Costa, and D. Robertson
Uncoupling of the Baroreflex by NN-Cholinergic Blockade in Dissecting the Components of Cardiovascular Regulation
Hypertension, July 1, 1998; 32(1): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. E. Handy and H. Gavras
Evidence for Cell-Specific Regulation of Transcription of the Rat {alpha}2A-Adrenergic Receptor Gene
Hypertension, April 1, 1996; 27(4): 1018 - 1024.
[Abstract] [Full Text]